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Abstract
Background: Infection by Hepatitis B virus (HBV) and Hepatitis C virus (HCV) cause serious mortality, morbidity and
financial burden and are thus a major global health problem. The study was conducted to investigate the
prevalence of Hepatitis B and C infections and co-infections among blood donors in a rural community of Ghana.
This was a retrospective study conducted at the Agogo Presbyterian Hospital in the Asanti Akim North District of
Ghana to investigate the prevalence of these infections over a three year period among 2773 blood donors. Males
constituted a larger proportion of the study population (92.2%). Majority of the study population (43.9%) were
within 26-35 age group. The disease prevalence was calculated at a 95% confidence interval.
Findings: The prevalence of Hepatitis B viral (HBV) infection was highest in females- 21.4% (95% CI: 11.6-34.4) in
2006 than males in the same year- 13.2% (95% CI: 10.8-15.9). Hepatitis C viral (HCV) infection was highest among
males- 11.6% (95% CI: 9.5-13.8) in 2007. HBV and HCV co-infection was higher in males- 2.6% (95% CI: 1.6-3.8) than
females- 1.3% (95% CI: 0-7.0) in 2007. The overall prevalence of HBV and HCV was 13.8% (95% CI: 11.4- 16.4) and
9.4% (95% CI: 7.4-11.6) respectively in 2006. The rate of co-infection of HBV and HCV however increased from 1.6%
(95% CI: 0.8-2.7) in 2006 to 2.2% (95% CI: 1.3-3.2) in 2008 in males and from 0% (95% CI: 0-6.4) in 2006 to 1.2%
(95% CI: 0-6.5) in 2008 in females.
Conclusion: The single infections of HBV and HCV reduced but co-infection of these transfusion transmitted
infections increased. Measures such as more sensitive techniques for effective diagnosis and sanitary education to
enlighten the population must be implemented.
Introduction
Hepatitis B is one of most common infectious diseases
of the world infecting two billion people including an
estimated 400 million chronically infected cases [1].
Individuals with chronic infection have a high risk of
developing liver cirrhosis and hepatocellular carcinoma.
Hepatitis C virus infection is another common chronic
blood borne infection with an estimated 3.9 million per-
sons infected with the virus and have a high rate of
development of liver cirrhosis. Infection by Hepatitis B
virus (HBV) and Hepatitis C virus (HCV) cause serious
mortality, morbidity and financial burden and are thus a
major global health problem [2]. Few studies have
previously indicated the high prevalence of HBV in
Ghana [3,4] and predonation screening of blood donors
or screening of donated blood for HBV and HCV are
thus a routine practice. HCV is recognized as the pri-
mary cause of transfusion-associated non-A-non-B viral
hepatitis worldwide [5] and is endemic in West Africa
[6]. In 1996, Martinson and his group conducted a ser-
oepidemiological survey of Hepatitis B and C virus
infections in children attending school in Ashanti-Akim
North district and showed that the overall HBV and
HCV seroprevalence was 15.8% and 5.4% respectively
[4] but recent studies conducted among blood donors in
Ethiopia has shown decreasing trends of HBV and HCV
[7]. From the Biostatistics department of the hospital,
the prevalence of HBV and HCV in 2007 stood at 15.1%
and 7.9% respectively (unpublished data).
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Ghana are old, scanty or limited to only urban blood
donors. The study aim was therefore to determine the
prevalence of HBV and HCV in blood donors in a rural
area over a three year period (2006-2008).
Methods
Study site
The Agogo Presbyterian Hospital is located in the Asanti
Akim North District of the Ashanti Region of Ghana,
West Africa; and is the principal hospital of the district.
The District is located in the eastern part of Ashanti
Region and covers a land area of 1,160 km
2 with an esti-
mated population of 142,434 (projection from 2000
Population Census). The catchment population of the
hospital encompasses around 70,000 people, about
25,000 in Agogo itself. Agogo is surrounded by hills cov-
ered with tropical secondary forests, subsistence and
small commercial acreages, grass and bush land that had
emerged after forest clearing due to logging and farming
activities. The most important cash crops are cocoa and
oil palm. Bananas, plantains, yams, cassava and maize are
the most important crops for subsistence farming.
Study population
This consisted of voluntary and replacement donors
who presented to the blood bank of the hospital.
Between January 2006 and December 2008, serological
screening results from 2773 blood donors were obtained
from the hospital’s archive. Prospective donors between
the ages of 17-60 years who pass a history screen of
their medical and physical state and predonation screen-
ing test for Hb level, HBV, HCV, Syphilis and HIV were
considered fit to donate blood.
Sampling
The screening of blood donors or donated blood for
HBsAg and anti-HCV is mandatory thus blood dona-
tions from individuals who are found to be positive for
any of the above infections were not done. Archived
results from the hospitals blood bank was used for this
study with approval from the hospital authorities. The
donor samples were tested using the DiaSpot
® One Step
Hepatitis test kits (DiaSpot Rapid Diagnosis, Pondok
Kelapa 13450, Jakarta Indonesia). The tests were carried
out according to the manufacturer’s instructions.
Quality control
In house positive and negative controls were performed
for each reagent lot.
Statistical analysis
Data were double-entered into a predesigned electronic
database using Epi info version 6.04dfr (Center for
Disease Control, Atlanta, GA, USA) and cleaned. Data
was exported to Stata/SE11.1 statistical software (Stata
Corporation, Texas USA) for analysis. The prevalence
was calculated at a 95% confidence interval.
Ethical Approval
Ethical approval for the study was obtained from the
Committee on Human Research, Publication and Ethics
(CHRPE), of the School of Medical Sciences, KNUST-
Kumasi.
Results
A total of 2773 prospective blood donors were screened
from January 2006 to December 2008. Study partici-
pants were grouped into five age categories (Table 1).
Out of these, 2556 (92.2%) were males and 217 (7.8%)
were females. Donors were categorized into five age
groups. The majority of the study population- 1217
(43.9%) - were within the 26-35 age group. Analysis of
the prevalence of HBV and HCV among males and
females revealed a statistically significant decrease in the
occurrence of the infections among males and females
(Table 2). Of the total number, 10.53% (292/2773),
5.63% (156/2773) and 2.09% (58/2773) were HBV, HCV
and both HBV and HCV positive, respectively. Further-
more, the prevalence of co-infection of HBV and HCV
decreased for the years under review with the highest
rate peaking at 2.6% (95% CI: 1.6-3.6) in 2007 (Figure
1). The overall prevalence rate for HBV was highest in
2006 (13.8%; 95% CI: 11.4-16.4) but decreased in 2008
to 6.9% (95% CI: 5.4-8.6) (Figure 2). The overall preva-
lence of HCV was highest in 2007 (11.1%; 95% CI: 9.2-
13.2) but decreased to 7.0% (95% CI: 5.5-8.8) in 2008.
The prevalence rate of HBV was relatively higher in
females but vice versa for HCV (Figure 3).
Discussion
HBV and HCV infections occurrence among blood
donors in a rural setting was determined by serological
methods and the results were compared to assess the
trends in three consecutive years, 2006, 2007 and 2008.
The prevalence of viral carrier rates in the blood donors
appears to be different to that of urban blood donors as
shown in the data with a decrease in HBV and HCV.
Table 1 Age categories of the study population
2006 2007 2008 Total
Age Group Male Female Male Female Male Female
16-25 194 25 198 37 254 49 757
26-35 297 15 450 21 413 21 1217
36-45 152 5 183 13 203 9 565
46-55 64 5 61 4 61 5 200
56-65 7 6 8 2 11 0 34
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and HCV in urban blood donors [7-9]. Simultaneous
increase of HBV and HCV infections might have been
caused by sexual transmission through unprotected sex
and other practices [10-12]. Our study raises serious
concerns regarding the safety of the blood supply in our
rural communities where resources are hard to come
by. The decreasing rate of positivity to HBV and HCV
or both suggests that horizontal rather than vertical
transmission is the major source of this endemicity [10].
In areas of low endemicity, transmission occurs primar-
ily among young adults [13] and there is an age effect
on the prevalence of HBV and HCV infections [14].
Horizontal transmission of HBV and HCV have been
related to age, socioeconomic conditions, socio profes-
sional status and risky behaviors such as sharing of bath
towels, chewing gum, partially eaten candies, or dental
cleaning materials, as well as biting fingernails in con-
junction with scratching the backs of carriers [15-17]. It
has been shown that the improvement of socioeconomic
conditions may lead to a decreasing exposure to HBV
and HCV infections [17] thus an increased risk of HBV
and HCV infections might be related to an increased
exposure to risk factors in conjunction with poor sani-
tary and socioeconomic conditions. The decreasing
trend of HBV and HCV infections in our study popula-
tion might be due to decreased exposure to risk factors
in conjunction with improving sanitary and socioeco-
nomic conditions. The fact that our study community is
being educated through weekly radio health talk pro-
grammes on these diseases in terms of good life style
practices such as having protected sex, not sharing
razors and needles with other people among others are
been adhered to. Another possible reason might be the
fact that screening of blood donors for HBsAg and anti-
HCV does not totally eliminate the risk of HBV and
HCV infection through blood transfusion since donors
with occult HBV and HCV infection which lacked
detectable levels of HBsAg and anti-HCV [18] were
screened as negative. This emphasizes the need for a
more sensitive and stringent screening algorithm for
blood donations even in rural settings.
Conclusion
HBV and/or HCV infection(s) among blood donors in
the study area is/are reducing. The occurrence of these
Table 2 Co-infection of HBV/HCV from 2006 to 2008
Prevalence at 95% CI
HBV only HCV only Both HBV and HCV Overall Prevalence
Year Male Female Male Female Male Female HBV HCV Both HBV and HCV
2006 13.2
† 21.4 10.1 0 1.6 0 13.8 9.4 1.6
(10.8-15.9)* (11.6-34.4) (8.0-12.5) (0-6.4) (0.9-2.9) (0-6.4) (11.4-16.4) (7.4-11.6) (0.8-2.7)
2007 11.3 16.9 11.6 5.2 2.6 1.3 11.8 11.1 2.6
(9.3-13.6) (9.3-27.1) (9.5-13.8) (1.4-12.8) (1.6-3.8) (0-7.0) (9.8-14.0) (9.2-13.2) (1.6-3.6)
2008 6.7 9.5 7.3 3.6 2.2 1.2 6.9 7 2.2
(5.2-8.5) (4.2-17.9) (5.7-9.2) (0.7-10.1) (1.4-3.4) (0-6.5) (5.4-8.6) (5.5-8.8) (1.3-3.2)
† Percentage prevalence
* Confidence interval
Figure 1 HBV and HCV co-infection among males and females. Figure 2 Overall prevalence of HBV and HCV infection.
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Page 3 of 4infections among the blood donors should still be moni-
tored carefully to further reduce the rates to ensure
safer and more reliable blood for transfusion. Measures
such as more sensitive techniques, education, sensitiza-
tion and vaccination must be carried out to ensure that
people are well enlightened and protected from these
infections.
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Figure 3 Prevalence of HBV and HCV infection among males
and females.
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